US FDA Warning Letters of CAPA Violations: A Review

Author(s): Pavan Deshpande, Rutuja Agawane, Sarath C. Tatikola, Surenahalli G. Vasantharaju*

Journal Name: Applied Clinical Research, Clinical Trials and Regulatory Affairs

Volume 7 , Issue 2 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

United States Food and Drug Administration (USFDA) is a federal agency functioning under United States Federal Executive Departments, which strives to regulate the food products and drug substances being manufactured or brought into US market, upholding Quality and Safety as prime goals. It takes care of its goals by inspecting firms which market products in the United States. It chalks out good manufacturing procedures for obtaining quality end-products. Based on inspections conducted and data collected thereby, those not abiding by rules shall be issued with Warning Letters and marketing license shall be cancelled for those who fail to justify the warning letter. This brings about discipline amongst manufacturers and sets a goal of quality that needs to be achieved to survive in market.

Keywords: CAPA, USFDA, warning letters, US healthcare, violations, regulated markets.

[1]
Spring S,, Limited L,. Complex BK food TUS. Lupin Limited 2018;; 351(2): :1-7.
[26]
[63]
Food and drug administration Poly drug laboratories Pvt 2016 Available from: http://www.fda.gov/ICECI/EnforcementActions/War ning Letters/2016/ucm496623.htm


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 7
ISSUE: 2
Year: 2020
Page: [85 - 92]
Pages: 8
DOI: 10.2174/2213476X06666191015114427

Article Metrics

PDF: 11
HTML: 1